Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experience

• Main Authors: Malak Moubarak (Author), Philipp Harter (Author), Beyhan Ataseven (Author), Alexander Traut (Author), Julia Welz (Author), Thais Baert (Author), Florian Heitz (Author)
• Format: Book
• Published: Elsevier, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: We aimed to evaluate real-life experiences with the re-challenge of poly(ADP-Ribose)Polymerase (PARP) inhibitors (PARPi) after a prior PARPi therapy in patients with recurrent EOC. Methods: A retrospective descriptive study was conducted at a tertiary care center of excellence for ovar...